The future of drug toxicity testing?
UK-based NanoBioDesign has received further investment to aid in its commercialisation of a tool for testing drugs on P450 liver enzymes, which could dramatically speed up drug toxicity testing.
Archives for July 8, 2007
Alzheimer's patch gets stuck into US market
The first and only transdermal treatment for Alzheimer's disease has been approved in the US.
Multi-faceted drug adds arthritis string to its bow
A UK biopharma firm's lead drug candidate has now shown good preclinical results for rheumatoid arthritis, adding to its clinical efficacy in Alzheimer's.
AstraZeneca and Roche jump on siRNA bandwagon
AstraZeneca (AZ) and Roche have became the latest big pharma firms to invest in RNA interference (RNAi), having penned separate licensing deals with two of the industry's leading specialists in the field.
Dishman to buy Solvay fine chemicals unit
Indian contract manufacturing organisation (CMO) Dishman Pharmaceuticals has announced its plans to buy Solvay Pharmaceuticals' fine chemicals and vitamin businesses for an undisclosed sum.
Quintiles to expand US central lab
Quintiles is planning to spend $19m ($14m) to consolidate its US central lab and its clinical services office in Georgia to one location and expand capacity at the same time.
Helvoet burns rubber to stay ahead of injectables market
The world's number two manufacturer of rubber components for pharmaceutical products, Helvoet Pharma, has broken ground on a new facility that promises to double or even triple its capacity to supply the fast-growing markets for injectable biologics...